Javascript must be enabled to continue!
Regulation of the p38-MAPK pathway by hyperosmolarity and by WNK kinases
View through CrossRef
Abstract
p38-MAPK is a stress-response kinase activated by hyperosmolarity. Here we interrogated the pathways involved. We show that p38-MAPK signaling is activated by hyperosmotic stimulation in various solutions, cell types and colonic organoids. Hyperosmolarity sensing is detected at the level of the upstream activators of p38-MAPK: TRAF2/ASK1 (but not Rac1) and MKK3/6/4. While WNK kinases are known osmo-sensors, we found, unexpectedly, that short (2 hrs) inhibition of WNKs (with WNK463) led to elevated p38-MAPK activity under hyperosmolarity, which was mediated by WNK463-dependent stimulation of TAK1 or TRAF2/ASK1, the upstream activators of MKK3/6/4. However, this effect was temporary and was reversed by long-term (2 days) incubation with WNK463. Accordingly, 2 days (but not 2 hrs) inhibition of p38-MAPK or its upstream activators ASK1 or TAK1, or WNKs, diminished regulatory volume increase (RVI) following cell shrinkage under hyperosmolarity. We also show that RVI mediated by the ion transporter NKCC1 is dependent on p38-MAPK. Since WNKs are known activators of NKCC1, we propose a WNK->NKCC1->p38-MAPK pathway that controls RVI. This pathway is augmented by NHE1. Additionally, hyperosmolarity inhibited mTORC1 activation and cell proliferation. Thus, hyperosmotic activation of p38-MAPK and WNKs is important for RVI and for cell proliferation.
Research Square Platform LLC
Title: Regulation of the p38-MAPK pathway by hyperosmolarity and by WNK kinases
Description:
Abstract
p38-MAPK is a stress-response kinase activated by hyperosmolarity.
Here we interrogated the pathways involved.
We show that p38-MAPK signaling is activated by hyperosmotic stimulation in various solutions, cell types and colonic organoids.
Hyperosmolarity sensing is detected at the level of the upstream activators of p38-MAPK: TRAF2/ASK1 (but not Rac1) and MKK3/6/4.
While WNK kinases are known osmo-sensors, we found, unexpectedly, that short (2 hrs) inhibition of WNKs (with WNK463) led to elevated p38-MAPK activity under hyperosmolarity, which was mediated by WNK463-dependent stimulation of TAK1 or TRAF2/ASK1, the upstream activators of MKK3/6/4.
However, this effect was temporary and was reversed by long-term (2 days) incubation with WNK463.
Accordingly, 2 days (but not 2 hrs) inhibition of p38-MAPK or its upstream activators ASK1 or TAK1, or WNKs, diminished regulatory volume increase (RVI) following cell shrinkage under hyperosmolarity.
We also show that RVI mediated by the ion transporter NKCC1 is dependent on p38-MAPK.
Since WNKs are known activators of NKCC1, we propose a WNK->NKCC1->p38-MAPK pathway that controls RVI.
This pathway is augmented by NHE1.
Additionally, hyperosmolarity inhibited mTORC1 activation and cell proliferation.
Thus, hyperosmotic activation of p38-MAPK and WNKs is important for RVI and for cell proliferation.
Related Results
Nudge‐nudge, WNK‐WNK (kinases), say no more?
Nudge‐nudge, WNK‐WNK (kinases), say no more?
Contents
Summary
35
I
Overview of animal and plant WNK kinases
35
II.
Structure: domains and topology
36
III.
Phylogeny–evolutionary relationships
41
IV.
Plant WNK kin...
SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylation
SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylation
Mutations in the WNK [with no lysine (K) kinase] family instigate hypertension and pain perception disorders. Of the four WNK isoforms, much of the focus has been on WNK1, which is...
Tracking and Inhibiting Atypical Vascular Inflammation
Tracking and Inhibiting Atypical Vascular Inflammation
Mitogen‐activated protein kinase (MAPK) p38 drives the onset and progression of many clinically challenging diseases. However, three decades of research have failed to yield clinic...
Abstract 920: COP1 E3 ligase regulates response to oncogenic MAPK pathway inhibition
Abstract 920: COP1 E3 ligase regulates response to oncogenic MAPK pathway inhibition
Abstract
Oncogenically activated RAS-MAPK pathway is the driver of several cancers including the majority of non-small cell lung adenocarcinomas (NSCLC). RAS-MAPK pa...
The CML-Microvesicles Are Enriched with Mirnas Regulating MAPK Signaling Pathway.
The CML-Microvesicles Are Enriched with Mirnas Regulating MAPK Signaling Pathway.
Abstract
Abstract 2786
Leukemia-cell-derived microvesicles (MVs) act as vehicles for exchange of genetic information between leukemia and nomal cells,...
Cheminformatics Analysis of Dynamic WNK‐Inhibitor Interactions
Cheminformatics Analysis of Dynamic WNK‐Inhibitor Interactions
AbstractThe With‐No‐Lysine (WNK) serine/threonine kinase family constitutes a unique and distinctive branch of the kinome. The four proteins of this family (WNK1/2/3/4) are involve...
The p38 MAP kinase pathway modulates the hypoxia response and glutamate receptor trafficking in aging neurons
The p38 MAP kinase pathway modulates the hypoxia response and glutamate receptor trafficking in aging neurons
Neurons are sensitive to low oxygen (hypoxia) and employ a conserved pathway to combat its effects. Here, we show that p38 MAP Kinase (MAPK) modulates this hypoxia response pathway...
p38 mitogen‐activated protein kinase signaling, ERCC1 expression, and viability of lung cancer cells from never or light smoker patients
p38 mitogen‐activated protein kinase signaling, ERCC1 expression, and viability of lung cancer cells from never or light smoker patients
AbstractBACKGROUND:Expression of DNA‐repair proteins and activated mitogen‐activated protein kinases (MAPKs) may differ according to smoking status. The authors investigated whethe...

